Atlas Venture Fund XII, L.P.

Insider Reports History

Location
Cambridge, MA
Signature
Atlas Venture Fund XII, L.P. By: Atlas Venture Associates XII, L.P., Its: General Partner By: Atlas Venture Associates XII, LLC, Its General Partner, By: /s/ Ommer Chohan, its CFO
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Atlas Venture Fund XII, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. 10%+ Owner Common Stock 2,327,909 $45,394,226 $19.50 15 Jul 2022 Direct
Vigil Neuroscience, Inc. 10%+ Owner Common Stock 0 $0 $8.05 05 Aug 2025 By Atlas Venture Opportunity Fund I, L.P.
Vigil Neuroscience, Inc. 10%+ Owner Common Stock 0 $0 $8.05 05 Aug 2025 Direct

Insider Reports Filed by Atlas Venture Fund XII, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VIGL Vigil Neuroscience, Inc. 05 Aug 2025 2 $0 4 10%+ Owner 07 Aug 2025, 17:00
JBIO Aerovate Therapeutics, Inc. 15 Jul 2022 1 $0 4 10%+ Owner 19 Jul 2022, 17:28
JBIO Aerovate Therapeutics, Inc. 01 Apr 2022 1 $0 4 10%+ Owner 04 Apr 2022, 17:13
VIGL Vigil Neuroscience, Inc. 11 Jan 2022 5 +$7,490,000 4 10%+ Owner 11 Jan 2022, 20:15
VIGL Vigil Neuroscience, Inc. 06 Jan 2022 0 $0 3 10%+ Owner 06 Jan 2022, 19:29
JBIO Aerovate Therapeutics, Inc. 02 Jul 2021 3 +$7,499,996 4 10%+ Owner 06 Jul 2021, 16:26
JBIO Aerovate Therapeutics, Inc. 29 Jun 2021 0 $0 3 10%+ Owner 29 Jun 2021, 20:46